These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 13540358)

  • 1. [Suppurative meningitis caused by Escherichia coli treated by an intraspinal adapted bacteriophage].
    SEDALLIAN P; BERTOYE A; GAUTHIER J; MULLER JM; COURTIEU AL
    Lyon Med; 1958 Mar; 90(13):509-12. PubMed ID: 13540358
    [No Abstract]   [Full Text] [Related]  

  • 2. [Post-traumatic meningitis caused by pyocyanic bacilli treated with an intraspinal adapted bacteriophage].
    MARTIN P; MARTIN P
    Acta Chir Belg; 1959 Jan; 58(1):85-90. PubMed ID: 13660683
    [No Abstract]   [Full Text] [Related]  

  • 3. Naturally occurring bacteriophages lyse a large proportion of canine and feline uropathogenic Escherichia coli isolates in vitro.
    Freitag T; Squires RA; Schmid J
    Res Vet Sci; 2008 Aug; 85(1):1-7. PubMed ID: 17959211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adapted bacteriophages in the treatment of infections caused by antibiotic-resistant microorganisms].
    BERTOYE A; GAILLARD L; COURTIEU AL
    J Med Lyon; 1959 May; 40(945):465-71. PubMed ID: 13655000
    [No Abstract]   [Full Text] [Related]  

  • 5. Shiga toxin-producing Escherichia coli and their bacteriophages as a model for the analysis of virulence and stress response of a food-borne pathogen.
    Creuzburg K; Schmidt H
    Berl Munch Tierarztl Wochenschr; 2007; 120(7-8):288-95. PubMed ID: 17715821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of Escherichia coli O157:H7 in biofilm on stainless steel by treatment with an alkaline cleaner and a bacteriophage.
    Sharma M; Ryu JH; Beuchat LR
    J Appl Microbiol; 2005; 99(3):449-59. PubMed ID: 16108786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections.
    Nishikawa H; Yasuda M; Uchiyama J; Rashel M; Maeda Y; Takemura I; Sugihara S; Ujihara T; Shimizu Y; Shuin T; Matsuzaki S
    Arch Virol; 2008; 153(3):507-15. PubMed ID: 18188500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reactivation of formaldehyde-treated bacteriophage by irradiated bacteriophage].
    FLAMAND J
    C R Seances Soc Biol Fil; 1957; 151(6):1269-71. PubMed ID: 13511889
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of relapsing furunculosis by staphylococcal bacteriophage].
    BALTER M
    Gaz Med Fr; 1955 Feb; 62(4):303-8. PubMed ID: 14366173
    [No Abstract]   [Full Text] [Related]  

  • 10. [D'Herelle bacteriophage; a natural agent and therapeutic technic in the healing of infections].
    RAIGA A; VOITOT J
    Hopital; 1952 Sep; 40(614):265-71. PubMed ID: 13021854
    [No Abstract]   [Full Text] [Related]  

  • 11. [Meningitis caused by Escherichia coli type O26B6].
    FAUCON R; RAJAONERA F
    Bull Soc Pathol Exot Filiales; 1957; 50(5):633-8. PubMed ID: 13511080
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of amino acid residues at the active site of endosialidase that dissociate the polysialic acid binding and cleaving activities in Escherichia coli K1 bacteriophages.
    Jakobsson E; Jokilammi A; Aalto J; Ollikka P; Lehtonen JV; Hirvonen H; Finne J
    Biochem J; 2007 Aug; 405(3):465-72. PubMed ID: 17394421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of specific bacteriophage in the treatment of diphtheria].
    SIBIRTSEV GE; BEL'SKAIA TG; LAVROVA KV
    Pediatriia; 1953; 2():22-3. PubMed ID: 13120314
    [No Abstract]   [Full Text] [Related]  

  • 14. Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model.
    Matsuda T; Freeman TA; Hilbert DW; Duff M; Fuortes M; Stapleton PP; Daly JM
    Surgery; 2005 Jun; 137(6):639-46. PubMed ID: 15933632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of 136 Escherichia coli isolates from cases of neonatal meningitis and relationship with virulence.
    Houdouin V; Bonacorsi S; Bidet P; Bingen E
    Clin Microbiol Infect; 2007 Dec; 13(12):1207-10. PubMed ID: 17949439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of formaldehyde-treated bacteriophage on sensitive Colibacillus].
    BOURGAUX P
    C R Seances Soc Biol Fil; 1957; 151(6):1267-9. PubMed ID: 13511888
    [No Abstract]   [Full Text] [Related]  

  • 17. [Applications of bacteriophage].
    NICOLLE P
    Gaz Med Fr; 1952 Dec; 58(22):1319-21. PubMed ID: 14917213
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of phage in enteric diseases in children].
    EORSI M; JABLONSZKY L; MILCH H
    Nepegeszseguegy; 1953 Aug; 34(8):220-3. PubMed ID: 13144939
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preventive application of bacteriophage in newborn; preliminary communication].
    SZCZEPANSKA H
    Pediatr Pol; 1951 Apr; 26(4):415-22. PubMed ID: 14875390
    [No Abstract]   [Full Text] [Related]  

  • 20. CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: failure of empirical chemotherapy.
    Boyer-Mariotte S; Duboc P; Bonacorsi S; Lemeland JF; Bingen E; Pinquier D
    J Antimicrob Chemother; 2008 Dec; 62(6):1472-4. PubMed ID: 18772159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.